The Food and Drug Administration has approved Edarbi (azilsartan medoxomil). The medicine can be used to treat adults with high blood pressure. Clinical trials showed Edarbi to be more effective than two previously approved drugs, Diovan (valsartan) and Benicar (olmesartan), the agency said. The treatment blocks the action of the hormone angiotensin II, Takeda Pharmaceutical North America said in a release.
http://www.tpna.com/
